Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20040220659 A1
Publication typeApplication
Application numberUS 10/858,589
Publication dateNov 4, 2004
Filing dateJun 2, 2004
Priority dateNov 2, 2000
Also published asDE60143364D1, EP1385691A2, EP1385691B1, EP2275248A1, US6770086, US20020111667, WO2002036332A2, WO2002036332A3
Publication number10858589, 858589, US 2004/0220659 A1, US 2004/220659 A1, US 20040220659 A1, US 20040220659A1, US 2004220659 A1, US 2004220659A1, US-A1-20040220659, US-A1-2004220659, US2004/0220659A1, US2004/220659A1, US20040220659 A1, US20040220659A1, US2004220659 A1, US2004220659A1
InventorsTimothy Girton
Original AssigneeScimed Life Systems, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Stent covering formed of porous polytetraflouroethylene
US 20040220659 A1
Abstract
An endoprosthesis device and method of making it are disclosed. More particularly, the endoprosthesis is a porous PTFE article used in conjunction with a stent.
Images(8)
Previous page
Next page
Claims(13)
1. An endoprosthesis device comprising:
an elongate radially expandable tubular stent having an interior surface and an exterior surface extending along a longitudinal stent axis; and
a stent cover on said interior surface, exterior surface or both, said stent cover being formed of a polytetrafluoroethylene having no node and fibril structure;
wherein said porous polytetrafluoroethylene is formed by the steps of:
providing an interpenetrating network of siloxane/polytetrafluoroethylene;
removing said siloxane from said interpenetrating network leaving a porous polytetrafluoroethylene structure without a node and fibril structure.
2. The endoprosthesis device of claim 1 wherein said stent cover is on said exterior surface and said interior surface of said stent.
3. The endoprosthesis device of claim 1 wherein said stent cover is expandable upon expansion of said stent.
4. The endoprosthesis device of claim 1 wherein said siloxane is chemically extracted from said siloxane/polytetrafluoroethylene interpenetrating network.
5. The endoprosthesis device of claim 4 wherein said siloxane is chemically extracted by a compound selected from the group consisting of toluene, heptane and chloroform.
6. The endoprosthesis device of claim 1 wherein said siloxane is removed from said siloxane/polytetrafluoroethylene interpenetrating network by heating said network to a temperature of at least about 300° C.
7-12 (canceled).
13. An endoprosthesis device comprising:
an elongate radially expandable tubular stent having an interior surface and an exterior surface extending along a longitudinal stent axis; and
a stent cover on said interior surface, exterior surface or both, which is formed of a polytetrafluoroethylene having no node and fibril structure;
wherein said porous polytetrafluoroethylene comprises a porous structure—having voids intermeshed between pockets of PTFE without a node and fibril structure.
14 (canceled).
15. The endoprosthesis device of claim 13 wherein said stent cover is on said exterior surface and said interior surface of said stent.
16. The endoprosthesis device of claim 13 wherein said stent cover is expandable upon expansion of said stent.
17. The endoprosthesis device of claim 1 wherein said siloxane is polydimethylsiloxane.
18. The method of claim 7 wherein said siloxane is polydimethylsiloxane.
Description
    FIELD OF THE INVENTION
  • [0001]
    The present invention relates to an endoprosthesis device or intraluminal device, in particular a stent, having a covering comprising porous polytetrafluoroethylene formed by removing the siloxane from an interpenetrating network of polytetrafluoroethylene and siloxane, and to a method of making the endoprosthesis device. The stent covering can be applied on the exterior surface of the stent, on the interior surface of the stent, or both, at a thickness of as low as about 15 microns.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Endoprosthesis devices including stents, stent-grafts, grafts, vena cava filters, balloon catheters, and so forth, are placed or implanted within various body vessels for the treatment of various diseases. One particular type of an endoprosthesis device is the stent. A stent is implanted within a vessel for the treatment of stenoses, strictures, or aneurysms in the blood vessels. The devices are implanted within the vascular system to reinforce diseased, partially occluded, weakened or abnormally dilated sections of the blood vessel. Stents are often employed after angioplasty to prevent restenosis of a diseased blood vessel. While stents are most notably used in blood vessels, they have also been implanted in other bodily vessels including urinary tracts and bile ducts to reinforce and prevent neoplastic growth.
  • [0003]
    Stents are typically longitudinal tubular devices formed of biocompatible materials and come in a variety of construction types, and are often expandable in nature. Many if not all of the materials used for stents involve metal or carbon fiber materials which are highly electro-positive and are bio-active. Since stents tend to be used under conditions were they are counteracting disease processes, supporting healing processes, or guarding against stenosis of a passage, bio-activity, which may encourage undesirable or poorly regulated growth processes, or lead to clot formation, should be avoided.
  • [0004]
    Coating of the stent can keep the stent from directly contacting surrounding tissue or fluids, and thus can theoretically protect against unwanted electrochemically induced tissue reactions.
  • [0005]
    In the field of expandable stents, a further problem arises due to the fact that many stent constructions involve structures that have numerous apertures or spaces between various strands or structural elements of the stent such as those structures that are filamentous, wire-like, or of a tubular nature in which various openings have been cut or etched into the stent. With these constructions, tissue may grow through the openings of the stent. Furthermore, the stent itself may provoke a foreign body reaction and be both a stimulus for and a framework supporting, proliferative tissue growth, resulting, for example, in scar tissue or restenosis of the very region it is placed to control.
  • [0006]
    One approach to this drawback is to provide a coating, liner, cover or both, for the stent which prevents the healing or diseased layer of tissue from directly contacting the stent, or from passing through the stent in any way. Such liners may be formed, for example, of porous polytetrafluoroethylene (PTFE) which allows the passage of fluids and vital materials while serving as a barrier to tissue growth. However, when applying such a construction, a further difficulty which may arise is that the layer or sleeve of polymer must be attached to the stent for example, by staples or sutures at one end, or is prone to developing loose pockets or folds which might accumulate organic matter or lead to sepsis or unusual growth. Also, the necessarily thin liner material may detach or degrade. The risk of loose or unattached liner material is particularly great for constructions which utilize poorly adherent polymers, such as PTFE, or structures which seek to combine an expandable stent of stiff material, which changes both its dimension and its shape, with a dissimilar liner or shell.
  • [0007]
    One method for overcoming these problems is found in U.S. Pat. No. 6,010,529 in which tube of polymeric material, e.g. expanded polytetrafluoroethylene (PTFE), is passed through the interior of a stent body and is turned back upon itself over the stent to form a cuff. The assembly is then heated and the outer layer contacts and coalesces with the inner layer, closely surrounding the stent body within a folded envelope having a continuous and seamless end. Porosity is imparted to the PTFE by previous stretching or expansion the material.
  • [0008]
    Another type of covered stent which permits radial expansion is shown in WO 96/00103. As shown and described therein, a metallic expandable stent includes an outer covering of ePTFE. The ePTFE cover exhibits suitable expansion capabilities so as to enable the cover to expand upon expansion of the underlying stent. A polytetrafluoroethylene/lubricant blend may be extruded into a tube and the tube heated to remove the lubricant. Then, in order to impart the expandable characteristics to the ePTFE cover during formation of the ePTFE cover material, the ePTFE must undergo successive processing steps of expanding the material, sintering the material, radially dilating the material and resintering the dilated material, a procedure that is quite process intensive. The device described therefore requires precise manufacturing techniques and is extremely processing sensitive. Careful processing of the material forming the cover is required in order for the cover to exhibit sufficient expansion capabilities.
  • [0009]
    U.S. Pat. No. 5,824,046 describes a composite intraluminal device, in particular an elongate radially expandable tubular stent having an interior luminal surface and an opposed exterior surface extending along a longitudinal stent axis. A stent cover is formed of unsintered ePTFE which is expandable.
  • [0010]
    There remains a need in the art to provide a stent with a cover material that is sufficiently expandable, has the requisite barrier properties and yet allows the passage of fluids and vital materials, without requiring extensive processing procedures and is thus easily manufactured and applied to the stent.
  • SUMMARY OF THE INVENTION
  • [0011]
    The present invention relates to a method of forming porous polytetrafluoroethylene (PTFE) without having to stretch or expand the material, and to a radially expandable endoprosthesis device covered with the solid but expandable polymer covering comprising the porous PTFE material obtained using the method of the present invention. The porous PTFE covering physically isolates the endoprosthesis from surrounding blood and tissue.
  • [0012]
    Specifically, the porous PTFE is prepared by extracting siloxane from an interpenetrating network (IPN) of PTFE and siloxane, leaving behind a porous PTFE structure without having to expand and stretch the PTFE. Consequently, the PTFE material used in the endoprosthesis device coverings of the present invention is not expanded PTFE, but it is porous.
  • [0013]
    In one embodiment the end of the prosthesis device of the present invention includes an elongate radially expandable tubular stent having an interior surface and in exterior surface extending along a longitudinal stent access. The expandable tubular stent has a stent cover on said interior surface, exterior surface or both, the cover being formed of a porous polytetrafluoroethylene. The porous polytetraflouroethylene cover is a non-stretched porous structure, the non-stretched structure lacking note and viable structure.
  • [0014]
    In particular, the present invention relates to a radially expandable stent for use in treating stenoses wherein the stent is covered with an expandable polymer covering comprising the porous PTFE prepared according to the present invention that physically isolates the stent from surrounding blood and tissue.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0015]
    [0015]FIG. 1 is a perspective view of one type of intraluminal device that may be used in the present invention.
  • [0016]
    [0016]FIG. 2 is a perspective view of a different intraluminal device which may be used in the present invention.
  • [0017]
    [0017]FIG. 3 is a perspective view of the intraluminal device of FIG. 1 illustrating the device having a polytetrafluoroethylene cover on both the inner and outer surface of the device.
  • [0018]
    [0018]FIG. 4 is a cross-sectional view of the same intraluminal device shown in FIG. 3.
  • [0019]
    [0019]FIG. 5 is the same intraluminal device as in FIG. 3 illustrating only the outer surface cover.
  • [0020]
    [0020]FIG. 6 is the same intraluminal device as in FIG. 3 with the exception that only a liner or inner surface cover is shown.
  • [0021]
    [0021]FIG. 7 is a cross-section of the porous PTFE material of the present invention.
  • [0022]
    [0022]FIG. 8 is a schematic representation of ePTFE prior art.
  • DETAILED DESCRIPTIONS OF THE PREFERRED EMBODIMENTS
  • [0023]
    The present invention provides a covered stent which may be implanted intraluminally within a body vessel and disposed adjacent an occluded, weakened or otherwise damaged portion of the vessel so as to hold the vessel open. The covered stent is typically delivered intraluminally via a balloon catheter. The device is delivered in a compressed condition and once properly positioned may be deployed by radial expansion. The most common form of deploying the intraluminal device is by balloon expansion, however, the present invention may also be deployed by use of a self-expanding stent.
  • [0024]
    [0024]FIG. 1 illustrates an intraluminal device in the form of a stent 12. FIG. 2 illustrates an intraluminal device in the form of a stent 5 having a different construction than that shown in FIG. 1.
  • [0025]
    [0025]FIG. 3 illustrates generally at 10 an intraluminal device in the form of a stent 12 as shown in FIG. 1 having a cover 14 on the outer surface 12 and liner 16 on the inner surface, both of which may be of the porous structure shown below in FIG. 7. The stent may optionally have only a cover 14 as shown in FIG. 5, or only a liner 16 as shown in FIG. 6, or both as shown in FIG. 3. In a preferred embodiment, the stent has both a cover 14 and a liner 16. The liner, cover, or both, will be referred to hereinafter collectively as a cover or covering. The cover provides an effective barrier about the stent 12 preventing excessive cell or tissue ingrowth or thrombus formation through the expanded wall of the stent 12.
  • [0026]
    [0026]FIG. 4 is a cross-sectional view of the same device as shown in FIG. 3 with a cover 14 and a liner 16 around stent 12.
  • [0027]
    [0027]FIG. 1 is a more detailed illustration of stent 10 and shows generally an elongate tube. The body of stent 12 defines an opposed interior surface 11 and an exterior surface 13 and is formed of a generally open configuration having a plurality of openings or passages provided for longitudinal flexibility of the stent as well as permitting the stent to be radially expanded once deployed in the body lumen. Both the interior surface 11 and the exterior surface 13 may have the porous PTFE covering of the present invention. On the interior surface the covering is referred to as the liner 12 as shown in FIG. 1 and on the exterior surface it is referred to as a cover 14 as shown in FIG. 1.
  • [0028]
    While the figures illustrate a particular construction of stent 10, one of skill in the art would recognize that the porous PTFE covering material as described by the present invention would find utility in any stent configuration, and in particular the open stent configurations.
  • [0029]
    Stent 12 may be employed in combination with a cover 14 or liner 16 but is preferably employed with both. The cover 14 may be applied over the tubular stent 12 so as to fully circumferentially surround the stent 12, while the liner 16 is applied inside and through the stent 12 so that the stent 12 fully circumferentially surrounds the liner 16.
  • [0030]
    The porous polytetrafluoroethylene (PTFE) material useful herein is first obtained in the form of an interpenetrating network of PTFE and siloxane, in particular, polydimethylsiloxane. The silicone is then extracted from the IPN using either thermal or chemical means. The removal of the silicone leaves behind a porous PTFE structure. A particular material for use herein is Silon®, an interpenetrating polymer network (IPN) of polytetrafluoroethylene (PTFE) and polydimethylsiloxane (silicone) supplied by Bio Med Sciences, Inc. located in Bethlehem, PA. Such IPN polymer networks are described in U.S. Pat. No. 6,022,902 incorporated by reference herein in its entirety. In this patent, Silon® is described as a breathable, hydrophobic polysiloxane membrane reinforced with poly(tetrafluoroethylene).
  • [0031]
    The removal of the siloxane from the IPN leaves behind a porous PTFE structure without having to go through the added steps of stretching or expanding the PTFE in order to obtain the porous structure. Quite obviously, this simplifies the manufacturing process by decreasing the number of steps required, and also increases efficiency. Typically, porous PTFE requires the expanding and stretching steps in order to achieve the porous structure. FIG. 7 illustrates generally at 20 a porous PTFE structure after removal of the siloxane. The removal of the siloxane leaves behind the porous structure wherein voids or pockets of air 25, are found intermeshed in between pockets of PTFE 30.
  • [0032]
    The novel porous PTFE structure produced by the present inventive process is quite different from the porous structure produced by PTFE which has been stretched, or expanded. Typically, PTFE which has been stretched, or ePTFE has a node and fibril structure as seen in FIG. 8. After stretching, the ePTFE possesses nodes 32 connected to fibrils 34. In between the nodes and fibrils are pores 36.
  • [0033]
    Removing the siloxane from the IPN of siloxane/PTFE through the use of heat involves heating the IPN structure to temperatures of between about 300° C. and about 390° C. Chemical removal of the siloxane may be accomplished using a compound selected from the group consisting of toluene, heptane, chloroform.
  • [0034]
    Sintering is typically accomplished at or above the crystalline melting point of PTFE. Sintering is synonymous with recrystallization. It refers to the bonding of particles in a mass by molecular (or atomic) attraction in the solid state through the application of heat below the melting point of the polymer. Sintering causes the strengthening of the powder mass and normally results in densification and often recrystallization.
  • [0035]
    A PTFE tube may be extruded as a tube from an extrusion device, or extruded as a film and subsequently wrapped into a tube. Extrusion techniques of PTFE are well known in the art.
  • [0036]
    As discussed above, the stent may be covered on the interior surface 11 of the stent 10, the exterior surface 13 of the stent 10, or both. Preferably, the stent 10 is covered on both the interior 11 and the exterior 13 surfaces of the stent 10. Having the entire surface of the stent 10 covered with the porous PTFE of the present invention provides an effective barrier about the stent 10 preventing excessive cell or tissue growth, or thrombus formation through the expanded wall of a tubular stent 10.
  • [0037]
    In order for the covering of porous PTFE to function effectively in combination with an expandable stent, the material must exhibit sufficient expansion characteristics so as to enable the stent cover to expand along with the radial expansion of the stent 10. If the covering material does not effectively expand with the stent, several problems can arise. The covering material may tear, and may even detach from the surface of the stent if improper or dissimilar expansion of the covering material occurs with the expansion of the stent.
  • [0038]
    In order to improve the adhesion, and further prevent detachment of the PTFE covering from the stent, the PTFE may be fused or welded around or to the metal stent. This may be accomplished either through a heating process and/or bonding process. If heating is utilized, typically the PTFE will be heated above its sintering temperature.
  • [0039]
    If an adhesive is utilized, preferably a biocompatible adhesive is used. Such adhesives are known to one of skill in the art and include, for example, polyurethanes, epoxies, cyanoacrylates, polyamides, polyimides, silicones, and so forth. Dispersions of PTFE or FEP (fluoroethylpropylene) may also be utilized. This list is not exclusive and is intended for illustrative purposes only, and is in no way intended as a limitation on the scope of the present invention. There is a vast number of adhesives that can be used for such applications, limited by their biocompatibility, and by their ability to bond to polymeric materials (e.g. PTFE) and metals, particularly in aqueous environments.
  • [0040]
    The covering material may also be assembled to the intraluminal device in more than one piece. Such a combination would require overlapping of sorts of the PTFE material, and subsequent fusion or adhesive bonding of the porous PTFE material to itself.
  • [0041]
    It is preferable, however, to utilize the porous PTFE covering in a continuous form such as a membrane or thin film. The porous PTFE (after removal of the siloxane), in the form of a membrane or a thin film, thus, preferably completely wraps the metal stent, thereby providing a barrier that physically isolates the stent from surrounding blood and tissue. This barrier further helps prevent healing or diseased layers of tissue from directly contacting the stent, or from passing through the stent in any way. The porous PTFE allows the passage of fluids and vital materials, however, while still serving as a barrier to tissue growth.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1978 *Feb 13, 1841 Manner of constructing- stoves
US3407249 *Feb 28, 1966Oct 22, 1968American Cyanamid CoPorous, extensively fibrillated polytetrafluoroethylene and method of preparing same
US4196070 *Dec 12, 1977Apr 1, 1980Nuclepore CorporationMethod for forming microporous fluorocarbon polymer sheet and product
US4289600 *Aug 7, 1979Sep 15, 1981Hooker Chemicals & Plastics Corp.Microporous membrane materials
US4304010 *Oct 12, 1979Dec 8, 1981Sumitomo Electric Industries, Ltd.Tubular polytetrafluoroethylene prosthesis with porous elastomer coating
US4321711 *Oct 12, 1979Mar 30, 1982Sumitomo Electric Industries, Ltd.Vascular prosthesis
US4533369 *Feb 3, 1984Aug 6, 1985Sumitomo Electric Industries, Ltd.Gas-permselective composite membranes and process for the production thereof
US4576608 *Nov 8, 1983Mar 18, 1986Homsy Charles APorous body-implantable polytetrafluoroethylene
US4605406 *Aug 3, 1984Aug 12, 1986Medtronic, Inc.Method for fabricating prosthesis material
US4657544 *Apr 18, 1984Apr 14, 1987Cordis CorporationCardiovascular graft and method of forming same
US4725273 *Aug 20, 1986Feb 16, 1988Kanegafuchi Kagaku Kogyo Kabushiki KaishaArtificial vessel having excellent patency
US4764560 *Aug 10, 1987Aug 16, 1988General Electric CompanyInterpenetrating polymeric network comprising polytetrafluoroethylene and polysiloxane
US4822361 *Dec 24, 1986Apr 18, 1989Sumitomo Electric Industries, Ltd.Tubular prosthesis having a composite structure
US4828772 *May 9, 1988May 9, 1989Millipore CorporationMicroporous membranes of ultrahigh molecular weight polyethylene
US4834746 *Mar 17, 1986May 30, 1989Kanegafuchi Kagaku Kogyo Kabushiki KaishaArtificial vessel and process for preparing the same
US4849285 *Jun 1, 1987Jul 18, 1989Bio Med Sciences, Inc.Composite macrostructure of ceramic and organic biomaterials
US4863604 *Feb 5, 1987Sep 5, 1989Parker-Hannifin CorporationMicroporous asymmetric polyfluorocarbon membranes
US4874568 *Sep 26, 1988Oct 17, 1989The Dow Chemical CompanyProcess of making a porous membrane
US4906377 *May 3, 1989Mar 6, 1990Millipore CorporationFluorocarbon membranes and process for making fluorocarbon membranes
US4945125 *Jan 5, 1987Jul 31, 1990Tetratec CorporationProcess of producing a fibrillated semi-interpenetrating polymer network of polytetrafluoroethylene and silicone elastomer and shaped products thereof
US4951381 *Oct 2, 1989Aug 28, 1990Alps Electric Co., Ltd.Method of manufacturing a magnetic head slider
US4963304 *Sep 26, 1988Oct 16, 1990The Dow Chemical CompanyProcess for preparing microporous membranes
US4986832 *Aug 25, 1988Jan 22, 1991Ube Industries, Ltd.Artificial blood vessel and process for preparing it
US4997603 *Nov 15, 1989Mar 5, 1991Hoechst Celanese Corp.Process for formation of halogenated polymeric microporous membranes having improved strength properties
US5066683 *May 1, 1990Nov 19, 1991Tetratec CorporationMicroporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof
US5098625 *Dec 17, 1990Mar 24, 1992Yeu Ming Tai Chemical Industrial Co., Ltd.Process for forming an expanded porous tetrafluoroethylene polymer
US5123917 *Apr 27, 1990Jun 23, 1992Lee Peter YExpandable intraluminal vascular graft
US5141522 *Jan 21, 1992Aug 25, 1992American Cyanamid CompanyComposite material having absorbable and non-absorbable components for use with mammalian tissue
US5157058 *Jun 7, 1991Oct 20, 1992Tetratec CorporationMicroporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof
US5198162 *Jun 13, 1989Mar 30, 1993Scimat LimitedMicroporous films
US5248428 *Dec 3, 1992Sep 28, 1993Minnesota Mining And Manufacturing CompanyArticle for separations and purifications and method of controlling porosity therein
US5433909 *Mar 12, 1993Jul 18, 1995Atrium Medical CorporationMethod of making controlled porosity expanded polytetrafluoroethylene products
US5466509 *Jan 15, 1993Nov 14, 1995Impra, Inc.Textured, porous, expanded PTFE
US5474128 *Jul 2, 1993Dec 12, 1995Best Tool Co., Inc.Telescoping conduits for increasing the fluid resistance of well production tubing inadvertently dropped in an oil or gas well
US5474824 *Jun 29, 1994Dec 12, 1995Atrium Medical CorporationProcess for expanding polytetrafluoroethylene and products produced thereby
US5607464 *Aug 27, 1993Mar 4, 1997Medtronic, Inc.Prosthetic vascular graft with a pleated structure
US5639278 *Nov 13, 1995Jun 17, 1997Corvita CorporationExpandable supportive bifurcated endoluminal grafts
US5641373 *Apr 17, 1995Jun 24, 1997Baxter International Inc.Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5693085 *Apr 26, 1995Dec 2, 1997Scimed Life Systems, Inc.Stent with collagen
US5700285 *Jun 7, 1995Dec 23, 1997W. L. Gore & Associates, Inc.Intraluminal stent graft
US5716660 *May 31, 1995Feb 10, 1998Meadox Medicals, Inc.Tubular polytetrafluoroethylene implantable prostheses
US5723526 *Apr 1, 1996Mar 3, 1998Teijin Chemicals LtdResin composition and molded article
US5735892 *Aug 18, 1993Apr 7, 1998W. L. Gore & Associates, Inc.Intraluminal stent graft
US5741326 *Jul 15, 1996Apr 21, 1998Cordis CorporationLow profile thermally set wrapped cover for a percutaneously deployed stent
US5744515 *Oct 11, 1996Apr 28, 1998Bsi CorporationMethod and implantable article for promoting endothelialization
US5749880 *Jul 27, 1995May 12, 1998Impra, Inc.Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5769884 *Jun 27, 1996Jun 23, 1998Cordis CorporationControlled porosity endovascular implant
US5776185 *Sep 26, 1995Jul 7, 1998Alessandro VeronaCardiovascular graft
US5782904 *Sep 29, 1994Jul 21, 1998Endogad Research Pty LimitedIntraluminal graft
US5788626 *Nov 18, 1996Aug 4, 1998Schneider (Usa) IncMethod of making a stent-graft covered with expanded polytetrafluoroethylene
US5810870 *Jun 7, 1995Sep 22, 1998W. L. Gore & Associates, Inc.Intraluminal stent graft
US5824046 *Sep 27, 1996Oct 20, 1998Scimed Life Systems, Inc.Covered stent
US5837752 *Jul 17, 1997Nov 17, 1998Massachusetts Institute Of TechnologySemi-interpenetrating polymer networks
US5840775 *Mar 4, 1997Nov 24, 1998E. I. Du Pont De Nemours And CompanyPorous polytetraflouroethylene and preparation
US5843161 *Jun 26, 1996Dec 1, 1998Cordis CorporationEndoprosthesis assembly for percutaneous deployment and method of deploying same
US5843173 *Apr 18, 1997Dec 1, 1998Baxter International Inc.Radially-enlargeable PTFE tape-reinforced vascular grafts and their methods of manufacture
US5861033 *Jan 30, 1997Jan 19, 1999Atrium Medical CorporationMethod of making controlled porosity expanded polytetrafluoroethylene products and fabrication
US5925074 *Dec 3, 1996Jul 20, 1999Atrium Medical CorporationVascular endoprosthesis and method
US5925075 *Jun 11, 1997Jul 20, 1999W. L. Gore & Associates, Inc.Intraluminal stent graft
US5928279 *Jul 3, 1996Jul 27, 1999Baxter International Inc.Stented, radially expandable, tubular PTFE grafts
US5928280 *Sep 10, 1996Jul 27, 1999William Cook Europe A/SExpandable endovascular stent
US5948191 *Oct 7, 1997Sep 7, 1999Cordis CorporationLow profile, thermally set wrapped cover for a percutaneously deployed stent
US5980799 *Jun 16, 1998Nov 9, 1999Atrium Medical CorporationMethods of making controlled porosity expanded polytetrafluoroethylene products and fabrication
US5980923 *Aug 11, 1997Nov 9, 1999Bio Med Sciences, Inc.Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
US6004348 *Apr 27, 1998Dec 21, 1999Impra, Inc.Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US6010529 *Dec 3, 1996Jan 4, 2000Atrium Medical CorporationExpandable shielded vessel support
US6015609 *Mar 20, 1997Jan 18, 2000Navartis AgProcess for manufacture of a porous polymer from a mixture
US6022902 *May 14, 1997Feb 8, 2000The United States Of America As Represented By The Administrator Of The National Aeronautics And Space AdministrationPorous article with surface functionality and method for preparing same
US6053943 *Dec 8, 1995Apr 25, 2000Impra, Inc.Endoluminal graft with integral structural support and method for making same
US6060530 *Mar 20, 1997May 9, 2000Novartis AgProcess for manufacture of a porous polymer by use of a porogen
US6143675 *Jun 6, 1996Nov 7, 2000W. L. Gore & Associates (Uk) Ltd.Porous composite
US6156064 *Aug 14, 1998Dec 5, 2000Schneider (Usa) IncStent-graft-membrane and method of making the same
US6190590 *Feb 28, 1996Feb 20, 2001Impra, Inc.Apparatus and method for making flanged graft for end-to-side anastomosis
US6235377 *Sep 5, 1995May 22, 2001Bio Med Sciences, Inc.Microporous membrane with a stratified pore structure created in situ and process
US6245099 *Sep 30, 1999Jun 12, 2001Impra, Inc.Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device
US6293969 *Dec 20, 1999Sep 25, 2001Endovascular Technologies, Inc.Bell-bottom modular stent-graft
US6361559 *Jun 10, 1999Mar 26, 2002Converge Medical, Inc.Thermal securing anastomosis systems
US6540780 *Nov 5, 1999Apr 1, 2003Medtronic, Inc.Porous synthetic vascular grafts with oriented ingrowth channels
US6702965 *Sep 20, 2001Mar 9, 2004BolloreMethod of forming a porous composite product, in particular with a high specific surface
US6770202 *Apr 13, 2000Aug 3, 2004Pall CorporationPorous membrane
US7083640 *Apr 30, 2004Aug 1, 2006C. R. Bard, Inc.Covered stent with encapsulated ends
US20020111667 *Nov 1, 2001Aug 15, 2002Scimed Life Systems, Inc.Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7955382Sep 14, 2007Jun 7, 2011Boston Scientific Scimed, Inc.Endoprosthesis with adjustable surface features
US7985252Jul 30, 2008Jul 26, 2011Boston Scientific Scimed, Inc.Bioerodible endoprosthesis
US7998192Aug 16, 2011Boston Scientific Scimed, Inc.Endoprostheses
US8002821Aug 23, 2011Boston Scientific Scimed, Inc.Bioerodible metallic ENDOPROSTHESES
US8048150Apr 12, 2006Nov 1, 2011Boston Scientific Scimed, Inc.Endoprosthesis having a fiber meshwork disposed thereon
US8052743Aug 2, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Endoprosthesis with three-dimensional disintegration control
US8052744Sep 13, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Medical devices and methods of making the same
US8052745Nov 8, 2011Boston Scientific Scimed, Inc.Endoprosthesis
US8057534Sep 14, 2007Nov 15, 2011Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8080055Dec 20, 2011Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8089029Feb 1, 2006Jan 3, 2012Boston Scientific Scimed, Inc.Bioabsorbable metal medical device and method of manufacture
US8128689Sep 14, 2007Mar 6, 2012Boston Scientific Scimed, Inc.Bioerodible endoprosthesis with biostable inorganic layers
US8236046Jun 10, 2008Aug 7, 2012Boston Scientific Scimed, Inc.Bioerodible endoprosthesis
US8267992Sep 18, 2012Boston Scientific Scimed, Inc.Self-buffering medical implants
US8303643Nov 6, 2012Remon Medical Technologies Ltd.Method and device for electrochemical formation of therapeutic species in vivo
US8382824Oct 3, 2008Feb 26, 2013Boston Scientific Scimed, Inc.Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8668732Mar 22, 2011Mar 11, 2014Boston Scientific Scimed, Inc.Surface treated bioerodible metal endoprostheses
US8715339Nov 21, 2011May 6, 2014Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8808726Sep 14, 2007Aug 19, 2014Boston Scientific Scimed. Inc.Bioerodible endoprostheses and methods of making the same
US8840660Jan 5, 2006Sep 23, 2014Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US20020111667 *Nov 1, 2001Aug 15, 2002Scimed Life Systems, Inc.Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture
Classifications
U.S. Classification623/1.15
International ClassificationA61L27/00, B29C67/20, A61F2/84, A61F2/06, A61L31/14, C08J9/26, A61L31/04, A61F2/90
Cooperative ClassificationA61F2/91, A61F2220/005, A61F2220/0058, A61F2220/0066, A61F2220/0075, A61F2002/91541, B29C67/202, A61L31/048, A61L31/146, A61F2/915
European ClassificationA61F2/915, A61F2/91, A61L31/04H, A61L31/14H, B29C67/20C
Legal Events
DateCodeEventDescription
Nov 6, 2006ASAssignment
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA
Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868
Effective date: 20050101
Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA
Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868
Effective date: 20050101